ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
Dow Jones
37.903,29
0,23%
Euro vs US Dollar
1,07178
0,00%
Bitcoin
57.281,13
-1,64%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Arcus Biosciences Inc (RCUS)

  7. Arcus Biosciences Inc (RCUS) News

RCUS

Arcus Biosciences (RCUS)

Arcus Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:RCUS
DatumZeitQuelleÜberschriftSymbolFirma
24/04/202422h00Business WireArcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual MeetingNYSE:RCUSArcus Biosciences Inc
23/04/202422h05Business WireArcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline UpdateNYSE:RCUSArcus Biosciences Inc
09/04/202422h35Business WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
26/03/202421h35Business WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
11/03/202421h35Business WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
28/02/202422h05Business WireArcus Biosciences to Participate in Two Upcoming Investor ConferencesNYSE:RCUSArcus Biosciences Inc
27/02/202422h35Business WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
21/02/202422h53Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:RCUSArcus Biosciences Inc
21/02/202422h32Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:RCUSArcus Biosciences Inc
21/02/202422h08Edgar (US Regulatory)Form 8-K - Current reportNYSE:RCUSArcus Biosciences Inc
21/02/202422h05Business WireArcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline UpdateNYSE:RCUSArcus Biosciences Inc
09/02/202422h35Business WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
08/02/202400h58Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
07/02/202423h00Business WireArcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline UpdatesNYSE:RCUSArcus Biosciences Inc
30/01/202414h17Edgar (US Regulatory)Form 8-K - Current reportNYSE:RCUSArcus Biosciences Inc
30/01/202412h25IH Market NewsArcus Biosciences Stock Jumps 20% on $320M Gilead Investment, Super Micro Surpasses Forecasts, and More NewsNYSE:RCUSArcus Biosciences Inc
29/01/202423h00Business WireGilead and Arcus Announce Amended Collaboration and Equity InvestmentNYSE:RCUSArcus Biosciences Inc
29/01/202423h00Business WireGilead and Arcus Announce Amended Collaboration and Equity InvestmentNYSE:RCUSArcus Biosciences Inc
26/01/202422h35Business WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
26/01/202401h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
26/01/202401h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
26/01/202401h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
16/01/202423h00Business WireData from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic CancerNYSE:RCUSArcus Biosciences Inc
22/12/202322h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
20/12/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
20/12/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
20/12/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
20/12/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
20/12/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
20/12/202322h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
 Showing the most relevant articles for your search:NYSE:RCUS

Kürzlich von Ihnen besucht

DBI
MDAX
MDAX
TG
BAYN
Bayer
NYSE
JPM
JP Morgan Chase
TG
RHM
Rheinmetall
NASDAQ
AAPL
Apple
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
LHA
Deutsche Lufthansa
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
TG
BAS
BASF
NASDAQ
MSFT
Microsoft
CCOM
US30
US 30
USOTC
BASFY
BASF (QX)
TG
MBG
MercedesBenz
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten